Preissner KT - Search Results

1

Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation.

Spranger J, Hammes HP, Preissner KT, Schatz H, Pfeiffer AF. Spranger J, et al. Among authors: preissner kt. Diabetologia. 2000 Nov;43(11):1404-7. doi: 10.1007/s001250051546. Diabetologia. 2000. PMID: 11126410

2

Integrin chatter and vascular function in diabetic retinopathy.

Preissner KT, Kanse SM, Hammes HP. Preissner KT, et al. Horm Metab Res. 1997 Dec;29(12):643-5. doi: 10.1055/s-2007-979118. Horm Metab Res. 1997. PMID: 9497904 Review.

3

Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides.

Chavakis E, Riecke B, Lin J, Linn T, Bretzel RG, Preissner KT, Brownlee M, Hammes HP. Chavakis E, et al. Among authors: preissner kt. Diabetologia. 2002 Feb;45(2):262-7. doi: 10.1007/s00125-001-0727-z. Diabetologia. 2002. PMID: 11935158

4

Topical application of integrin antagonists inhibits proliferative retinopathy.

Riecke B, Chavakis E, Bretzel RG, Linn T, Preissner KT, Brownlee M, Hammes HP. Riecke B, et al. Among authors: preissner kt. Horm Metab Res. 2001 May;33(5):307-11. doi: 10.1055/s-2001-15279. Horm Metab Res. 2001. PMID: 11440278 Clinical Trial.

5

Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.

Hoffmann J, Alt A, Lin J, Lochnit G, Schubert U, Schleicher E, Chavakis T, Brownlee M, Van der Woude FJ, Preissner KT, Hammes HP. Hoffmann J, et al. Among authors: preissner kt. Thromb Haemost. 2006 Apr;95(4):689-95. Thromb Haemost. 2006. PMID: 16601840

6

The functional role of blood platelet components in angiogenesis.

Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, Preissner KT. Rhee JS, et al. Among authors: preissner kt. Thromb Haemost. 2004 Aug;92(2):394-402. doi: 10.1160/TH03-04-0213. Thromb Haemost. 2004. PMID: 15269837

7

Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina.

Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT. Hammes HP, et al. Among authors: preissner kt. Lab Invest. 1996 Sep;75(3):325-38. Lab Invest. 1996. PMID: 8804356

8

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.

Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Hammes HP, et al. Among authors: preissner kt. Nat Med. 1996 May;2(5):529-33. doi: 10.1038/nm0596-529. Nat Med. 1996. PMID: 8616710

9

Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.

Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, Bdeir K. Chavakis T, et al. Among authors: preissner kt. FASEB J. 2004 Aug;18(11):1306-8. doi: 10.1096/fj.03-1009fje. Epub 2004 Jun 18. FASEB J. 2004. PMID: 15208269

10

Inhibition of pathologic retinal neovascularization by alpha-defensins.

Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J, Lu W, Preissner KT, Hammes HP, Chavakis T. Economopoulou M, et al. Among authors: preissner kt. Blood. 2005 Dec 1;106(12):3831-8. doi: 10.1182/blood-2005-03-0889. Epub 2005 Aug 25. Blood. 2005. PMID: 16123222 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters